Novel mechanisms for correcting opioid-induced synaptic abnormalities

纠正阿片类药物引起的突触异常的新机制

基本信息

  • 批准号:
    10610455
  • 负责人:
  • 金额:
    $ 45.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-15 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Abstract The US is facing a crisis of opioid overdoses and addiction. Current therapies consist largely of alternative opioids (i.e. maintenance with methadone or buprenorphine) and do not correct neurobiological factors that underlie drug craving and relapse. These factors include the long-lasting changes at glutamatergic synapses in the nucleus accumbens (NAc), which both resemble and differ from changes induced by other highly addictive drugs such as cocaine. Our recent studies suggest these synaptic effects of opioids are opposed by acid- sensing ion channels (ASICs). ASICs conduct inward Na+ and Ca2+ current at post-synaptic dendritic spines where they are activated during synaptic transmission by protons released into the synaptic cleft from neurotransmitter-containing vesicles. Because these protons are removed from the synaptic cleft via the actions of carbonic anhydrase 4 (CA4), genetically disrupting CA4 or pharmacologically inhibiting CA4 with acetazolamide (AZD) dramatically increases synaptic ASIC currents. These observations have led to our hypothesis that AZD will reverse synaptic changes following opioid withdrawal by inhibiting CA4 and increasing ASIC activity, and thereby reduce craving and relapse. In this proposal we plan to test this hypothesis by rigorously assessing effects of opioids on synaptic physiology and behavior. Together the experiments in this proposal will pave the way to a better understanding of the neurobiology underlying opioid addiction and to new molecular targets for treating opioid use disorder (OUD). Knowledge gained from these studies could suggest new ways to treat opioid addiction through non-opioidergic mechanisms, for example by manipulating ASICs, brain pH, or carbonic anhydrase, for which a number of inhibitors are already approved for human use, and might be efficiently repurposed.
摘要 美国正面临阿片类药物过量和成瘾的危机。目前的治疗主要包括替代疗法, 阿片类药物(即美沙酮或丁丙诺啡维持),并且不能纠正 导致毒瘾复发这些因素包括: 神经核(NAc),既类似于也不同于其他高度成瘾性药物引起的变化。 可卡因等毒品。我们最近的研究表明,阿片类药物的这些突触作用被酸- 传感离子通道(ASIC)。ASICs在突触后树突棘上传导内向Na+和Ca 2+电流 在突触传递过程中,它们被释放到突触间隙的质子激活, 含有神经递质的囊泡。因为这些质子是从突触间隙通过 碳酸酐酶4(CA 4)的作用,遗传上破坏CA 4或抑制CA 4, 乙酰唑胺(AZD)显著增加突触ASIC电流。这些观察导致我们 假设AZD将通过抑制CA 4逆转阿片类药物戒断后的突触变化, 增加ASIC活性,从而减少渴望和复发。在本提案中,我们计划测试这一点 通过严格评估阿片类药物对突触生理学和行为的影响,提出了这一假说。一起 这项提议中的实验将为更好地理解阿片类药物的神经生物学铺平道路 成瘾和治疗阿片类药物使用障碍(OUD)的新分子靶点。知识来自这些 研究可能会提出通过非阿片类药物机制治疗阿片类药物成瘾的新方法,例如 操纵ASIC、大脑pH值或碳酸酐酶,其中许多抑制剂已经被批准 供人类使用,并可能被有效地重新利用。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of acid-sensing ion channel-1A (ASIC1A) on cocaine-induced synaptic adaptations.
  • DOI:
    10.3389/fphys.2023.1191275
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Gupta, Subhash C.;Taugher-Hebl, Rebecca J.;Hardie, Jason B.;Fan, Rong;LaLumiere, Ryan T.;Wemmie, John A.
  • 通讯作者:
    Wemmie, John A.
Carbonic anhydrase 4 disruption decreases synaptic and behavioral adaptations induced by cocaine withdrawal.
  • DOI:
    10.1126/sciadv.abq5058
  • 发表时间:
    2022-11-18
  • 期刊:
  • 影响因子:
    13.6
  • 作者:
  • 通讯作者:
Investigating role of ASIC2 in synaptic and behavioral responses to drugs of abuse.
调查ASIC2在对滥用药物的突触和行为反应中的作用。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John A Wemmie其他文献

John A Wemmie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John A Wemmie', 18)}}的其他基金

Investigating a novel regulatory pathway for opioid-induced synaptic plasticity and behavior
研究阿片类药物诱导的突触可塑性和行为的新调控途径
  • 批准号:
    10516021
  • 财政年份:
    2019
  • 资助金额:
    $ 45.38万
  • 项目类别:
Investigating a novel regulatory pathway for opioid-induced synaptic plasticity and behavior
研究阿片类药物诱导的突触可塑性和行为的新调控途径
  • 批准号:
    10292973
  • 财政年份:
    2019
  • 资助金额:
    $ 45.38万
  • 项目类别:
Investigating a novel regulatory pathway for opioid-induced synaptic plasticity and behavior
研究阿片类药物诱导的突触可塑性和行为的新调控途径
  • 批准号:
    10066256
  • 财政年份:
    2019
  • 资助金额:
    $ 45.38万
  • 项目类别:
Basolateral amygdala circuits in defensive behavior regulation
基底外侧杏仁核回路在防御行为调节中的作用
  • 批准号:
    10311537
  • 财政年份:
    2018
  • 资助金额:
    $ 45.38万
  • 项目类别:
Brain pH and Acid Sensing in Depression-Related Behavior
抑郁相关行为中的大脑 pH 值和酸感应
  • 批准号:
    7929354
  • 财政年份:
    2010
  • 资助金额:
    $ 45.38万
  • 项目类别:
Brain pH and Acid Sensing in Depression-Related Behavior
抑郁相关行为中的大脑 pH 值和酸感应
  • 批准号:
    8597367
  • 财政年份:
    2010
  • 资助金额:
    $ 45.38万
  • 项目类别:
ASICs in the n. accumbens in depression-related synaptic plasticity and behavior
n 中的 ASIC。
  • 批准号:
    8967085
  • 财政年份:
    2010
  • 资助金额:
    $ 45.38万
  • 项目类别:
Brain pH and Acid Sensing in Depression-Related Behavior
抑郁相关行为中的大脑 pH 值和酸感应
  • 批准号:
    8196333
  • 财政年份:
    2010
  • 资助金额:
    $ 45.38万
  • 项目类别:
Brain pH and Acid Sensing in Depression-Related Behavior
抑郁相关行为中的大脑 pH 值和酸感应
  • 批准号:
    8391587
  • 财政年份:
    2010
  • 资助金额:
    $ 45.38万
  • 项目类别:
Modeling CO2-evoked fear in mice: role of acid-sensing ion channels
模拟二氧化碳引起的小鼠恐惧:酸敏感离子通道的作用
  • 批准号:
    8231507
  • 财政年份:
    2009
  • 资助金额:
    $ 45.38万
  • 项目类别:

相似海外基金

Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance
乙酰唑胺和醋甲唑胺对缺氧运动表现的影响
  • 批准号:
    572954-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 45.38万
  • 项目类别:
    University Undergraduate Student Research Awards
Acetazolamide to Improve Clinically Important Outcomes in Obstructive Sleep Apnea Patients with a High Loop Gain Endotype
乙酰唑胺可改善具有高环增益内型的阻塞性睡眠呼吸暂停患者的临床重要结果
  • 批准号:
    10524708
  • 财政年份:
    2022
  • 资助金额:
    $ 45.38万
  • 项目类别:
Development of a DNA Aptamer-Based Electrochemical Assay for Acetazolamide in Urine Using a Handheld Biosensor for Compliance Validation in Clinical Drug Trials
使用手持式生物传感器开发基于 DNA 适体的尿液中乙酰唑胺电化学检测方法,以验证临床药物试验的合规性
  • 批准号:
    9344796
  • 财政年份:
    2017
  • 资助金额:
    $ 45.38万
  • 项目类别:
Renoprotecion of acetazolamide and canagliflozin
乙酰唑胺和卡格列净的肾脏保护
  • 批准号:
    26461233
  • 财政年份:
    2014
  • 资助金额:
    $ 45.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯那胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    6846379
  • 财政年份:
    2004
  • 资助金额:
    $ 45.38万
  • 项目类别:
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯那胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    7673808
  • 财政年份:
    2004
  • 资助金额:
    $ 45.38万
  • 项目类别:
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯那胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    7356429
  • 财政年份:
    2004
  • 资助金额:
    $ 45.38万
  • 项目类别:
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯那胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    7749961
  • 财政年份:
    2004
  • 资助金额:
    $ 45.38万
  • 项目类别:
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯酰胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    6723860
  • 财政年份:
    2004
  • 资助金额:
    $ 45.38万
  • 项目类别:
Sequential Changes of Cerebral Blood Flow after Acetazolamide Acetazolamide Loading in Hemodynamic Cerebral Ischemia: Relationship to Cerebral Oxygen Metabolism
血流动力学脑缺血中乙酰唑胺负荷后脑血流量的连续变化:与脑氧代谢的关系
  • 批准号:
    15591541
  • 财政年份:
    2003
  • 资助金额:
    $ 45.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了